Gynécologie - Ovaires
AGO-OVAR 2.29
Atezolizumab in combination with Bevacizumab and Chemotherapy;versus Bevacizumab and Chemotherapy;in recurrent ovarian cancer À a randomized Phase III trial;An ENGOT Trial
Paris
MANUEL RODRIGUES